A 2026 overview of Found Health's GLP-1 medication access model, free online insurance coverage check, disclosed pricing for ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

The FDA has spent much of 2025 issuing warnings about a single, recurring problem with GLP-1 weight loss drugs: patients and ...

Hers just launched a new GLP‑1 weight loss membership starting at $39 for the first month. Here’s how it works, what’s included and how to join.

A 2026 informational overview of publicly available MEDVi tirzepatide GLP-1 pricing details, compounded medication access ...

NVO partners with HIMS to expand access to Ozempic and Wegovy via telehealth, aiming to shift patients from compounded GLP-1s ...

CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

In late March 2026, Hims & Hers Health, Inc. announced a renewed collaboration with Novo Nordisk to offer a broad range of FDA-approved GLP-1 medications, including Wegovy injections and the only ...

NEW YORK, Feb 19 (Reuters) - Online telehealth company Hims & Hers Health, seeking growth drivers as its original sexual-health franchises matured, may have overstepped with a risky launch of ...

Many Americans seeking popular weight-loss drugs like Wegovy and Zepbound turn to telehealth companies like Hims & Hers for cheaper, compounded alternatives. Those compounded drugs were only supposed ...